Protheragen Looks to Accelerate Autoimmune Disease Therapy by Offering Animal Model Development Services

Protheragen announces the launch of its professional animal model development services, to advance research in autoimmune diseases.
New York, USA - September 11, 2024 - To advance research in autoimmune diseases, Protheragen announces the launch of its professional animal model development services. These services are designed to accelerate the development of innovative therapies for autoimmune diseases by providing researchers with customized animal models for preclinical testing.

Image: https://www.getnews.info/uploads/f3689327e4f7f26d5f10eb2654202775.jpg

Autoimmune diseases are complex conditions that occur when the immune system mistakenly attacks the body's own tissues and organs. These diseases can be debilitating and challenging to treat, making them a significant focus of biomedical research and drug development efforts. To better understand the underlying mechanisms of autoimmune diseases and develop effective treatments, animal models are often used to mimic specific aspects of these conditions, providing valuable insights into the pathogenesis of autoimmune diseases and helping identify potential therapeutic targets.

With extensive expertise in immunology and biotechnology, Protheragen can provide researchers with high-quality, reliable models that closely replicate human autoimmune diseases. By combining innovative genetic engineering techniques (CRISPR/CAS9) and immunological insights, the company can develop relevant and predictive models for various autoimmune disorders including asthma, atopic dermatitis, type 1 diabetes, and psoriasis. Additionally, Protheragen can also offer chemically induced animal models, such as colitis and rheumatoid arthritis models. To validate the fidelity of autoimmune animal models [https://www.autoimmunetec.com/animal-models-development-service.html], Protheragen will conduct rigorous phenotypic and genotypic evaluations to ensure that the generated models exhibit the desired disease traits and pathological manifestations.

By offering customized animal models that closely reproduce the pathophysiology of autoimmune diseases, Protheragen hopes to empower global clients to advance their research and develop innovative therapies. Now, its animal model development services are available to researchers in the biopharmaceutical industry, academia, and government organizations. With a dedicated team of experts and state-of-the-art facilities, Protheragen is committed to providing the highest quality models and exceptional customer service.

About Protheragen

Protheragen is dedicated to meeting preclinical research needs in the study of autoimmune diseases. Whether researchers are conducting studies on new or modified medications, medical devices or therapeutic regimes for autoimmune diseases, Protheragen is here to help. With its skilled technical team and top-notch platform, the company can offer a wide range of autoimmune disease models, solutions for diagnostic development, and professional autoimmune disease services [https://www.autoimmunetec.com/] to expedite autoimmune disease research efforts.
Media Contact
Company Name: Protheragen
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=protheragen-looks-to-accelerate-autoimmune-disease-therapy-by-offering-animal-model-development-services]
Phone: 1-631-371-3915
Country: United States
Website: https://www.autoimmunetec.com



This release was published on openPR.